-
Mashup Score: 2Shawn Kwatra, MD, Reviews Late-Breaking Data of Abrocitinib for Prurigo Nodularis and Chronic Pruritus of Unknown Origin - 6 month(s) ago
Kwatra presented the abrocitinib data at EADV 2023.
Source: www.dermatologytimes.comCategories: Dermatology, Latest HeadlinesTweet
-
Mashup Score: 0Diversity Champion Workshop - 6 month(s) ago
Join other dermatology faculty champions virtually to discuss dermatology diversity outreach programs and initiatives, exchange ideas, and share success stories.
Source: www.aad.orgCategories: Dermatology, Latest HeadlinesTweet
-
Mashup Score: 1AAD.org Login - 6 month(s) ago
Create a non-member account if you are applying for m embership or need to interact with AAD systems. Non-member accounts do not have access to the member-only sections of our
Source: identity.aad.orgCategories: Dermatology, Latest HeadlinesTweet
-
Mashup Score: 0Home - 6 month(s) ago
This 90-minute, live, interactive symposium will feature expert faculty as well as a patient with immune thrombocytopenia (ITP) to underscore the value of the patient voice throughout the management of ITP. Expert faculty will provide a detailed overview of the mechanisms of ITP and its key clinical features, present diagnostic and treatment challenges and how to overcome them, as well as discuss data on current and emerging therapies to inform the best clinical choices for patients. A big emphasis will
Source: na.eventscloud.comCategories: Dermatology, Latest HeadlinesTweet
-
Mashup Score: 0Preparing Your Patient to Ask for ADA Workplace Accommodations - 6 month(s) ago
Sometimes patients are unsure of what they can request from an employer for their skin conditions, and advice from a trusted clinician about reasonable accommodations can serve as an extra step to build their confidence to continue their career.
Source: www.dermatologytimes.comCategories: Dermatology, Latest HeadlinesTweet
-
Mashup Score: 0Eczema Resources for Your Patients: Week 3 - 6 month(s) ago
Prepare your patients with helpful resources during National Eczema Awareness Month.
Source: www.dermatologytimes.comCategories: Dermatology, Latest HeadlinesTweet
-
Mashup Score: 1TYK2 as a Therapeutic Target in Psoriasis - 6 month(s) ago
Jeffrey M. Cohen, MD, discussed TYK2 inhibitors, a new class of therapy being studied for the treatment of psoriasis, on the first day of Fall Dermatology Week 2023.
Source: www.hmpgloballearningnetwork.comCategories: Dermatology, Latest HeadlinesTweet
-
Mashup Score: 0Pharma Sales 2.0 - Practical Dermatology - 6 month(s) ago
A behind-the-scenes look at how ReachRX aims to transform pharma sales and boost patient access.
Source: practicaldermatology.comCategories: Dermatology, Latest HeadlinesTweet
-
Mashup Score: 0Dermatology Pearls for Adverse Effects of Breast Cancer Treatments - 6 month(s) ago
Skin conditions can be associated with the presentation, progression, and treatment of breast cancer.
Source: www.dermatologytimes.comCategories: Dermatology, Latest HeadlinesTweet
-
Mashup Score: 0First Patient Dosed in Phase 2a Trial of IMG-007 for Alopecia Areata - 6 month(s) ago
Inmagene recently announced the first patient was dosed in its study of the efficacy and safety of IMG-007 in hair loss.
Source: www.dermatologytimes.comCategories: Dermatology, Latest HeadlinesTweet
New: @drshawnkwatra , discusses new late-breaking data on the safety and efficacy of #abrocitinib for the treatment #PrurigoNodularis and chronic #pruritus of unknown origin presented at EADV 2023. https://t.co/9MEEdTpzWf